Yes, and there should be
Topical GHK-Cu: Patient Perspectives The distinction between injectable and non-injectable GHK-Cu matters because different patient populations use different routes: Topical GHK-Cu Users Licensed Healthcare Practitioners 1,000+ physician-grade products, bulk-tier pricing, and direct shipping to your practice
Common adverse effects include gastrointestinal symptoms such as nausea (12-29% of patients), diarrhea (12-16%), vomiting (6-9%), and constipation (6-11%), with rates varying by dose
For chronic conditions, full assessment should occur after a complete 812 week cycle
mean values indicated
With the right strategiesgradual dose escalation, dietary modifications, adequate hydration, and when needed, anti-nausea medicationsmost people can successfully manage this side effect and continue benefiting from these powerful medications